Showing results (171-180 of 355) with videos related to
Sort By:
Pageof 36
Journal of Burn Care & Research : Official Publication of the American Burn Association|January 3, 2012
Assessment of combined muscarinic antagonist and fibrinolytic therapy for inhalation injuryCollette Jonkam, Yong Zhu, Sam Jacob, et al.Scientific Reports|September 16, 2020
Impact of ASA-score, age and learning curve on early outcome in the initiation phase of an oncological robotic colorectal programHülya Sarikaya, Tahar Benhidjeb, Sergiu I Iosivan, et al.Critical Care Medicine|October 11, 2013
Antithrombin attenuates vascular leakage via inhibiting neutrophil activation in acute lung injurySebastian Rehberg, Yusuke Yamamoto, Linda E Sousse, et al.Critical Care Medicine|September 24, 2016
Quality Improvement Initiative for Severe Sepsis and Septic Shock Reduces 90-Day Mortality: A 7.5-Year Observational StudyChristian S Scheer, Christian Fuchs, Sven-Olaf Kuhn, et al.Cardiovascular Drugs and Therapy|August 10, 2013
Renal effects of levosimendan: a consensus reportMehmet B Yilmaz, Elena Grossini, José C Silva Cardoso, et al.Journal of Leukocyte Biology|September 12, 2009
ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancerRieneke van de Ven, Ruud Oerlemans, Joost W van der Heijden, et al.Journal of Medicinal Chemistry|August 14, 2024
Synthesis and Characterization of Folic Acid-Conjugated Terbium Complexes as Luminescent Probes for Targeting Folate Receptor-Expressing CellsGrace T McMullon, Aiarpi Ezdoglian, Anna C Booth, et al.Blood|November 21, 2008
Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemiaRobert de Jonge, Wim J E Tissing, Jan Hendrik Hooijberg, et al.Exploration of Targeted Anti-Tumor Therapy|November 3, 2025
Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell linesPaweł Kochany, Janet H Stegehuis, Leonie H A M de Wilt, et al.Arthritis and Rheumatism|July 13, 2004
Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritisGerrit Jansen, Joost van der Heijden, Ruud Oerlemans, et al.Pageof 36